(D5BC) Xtrackers II Germany - Ratings and Ratios

Exchange: XETRA • Country: Germany • Currency: EUR • Type: Etf • ISIN: LU0468897110

Bonds, Government, Securities, Fixed-Income, Debt, Investments

Description: D5BC Xtrackers II Germany

URL: http://www.dws.lu Index: Morningstar EZN 1-3 Yr Tsy Bd GR EUR

Additional Sources for D5BC ETF

Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle

D5BC ETF Overview

Market Cap in USD 30m
Category EUR Government Bond - Short Term
TER 0.16%
IPO / Inception 2010-01-05

D5BC ETF Ratings

Growth Rating 6.58
Fundamental -
Dividend Rating 1.0
Rel. Strength 3.81
Analysts -
Fair Price Momentum 130.39 EUR
Fair Price DCF -

D5BC Dividends

Dividend Yield 12m 0.48%
Yield on Cost 5y 0.48%
Annual Growth 5y -18.07%
Payout Consistency 40.6%
Payout Ratio %

D5BC Growth Ratios

Growth Correlation 3m 55.9%
Growth Correlation 12m 96.6%
Growth Correlation 5y -40.9%
CAGR 5y -0.04%
CAGR/Max DD 5y -0.01
Sharpe Ratio 12m 0.23
Alpha -0.81
Beta -0.017
Volatility 0.93%
Current Volume 0.4k
Average Volume 20d 0.2k
What is the price of D5BC shares?
As of July 05, 2025, the stock is trading at EUR 139.41 with a total of 381 shares traded.
Over the past week, the price has changed by +0.00%, over one month by +0.04%, over three months by +0.59% and over the past year by +3.27%.
Is Xtrackers II Germany a good stock to buy?
Neither. Based on ValueRay´s Analyses, Xtrackers II Germany is currently (July 2025) neither a good nor a bad stock to buy. It has a ValueRay Growth Rating of 6.58 and therefor a technical neutral rating according to historical growth.
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of D5BC is around 130.39 EUR . This means that D5BC is currently overvalued and has a potential downside of -6.47%.
Is D5BC a buy, sell or hold?
Xtrackers II Germany has no consensus analysts rating.
What are the forecasts for D5BC share price target?
According to our own proprietary Forecast Model, D5BC Xtrackers II Germany will be worth about 140.8 in July 2026. The stock is currently trading at 139.41. This means that the stock has a potential upside of +1.01%.
Issuer Target Up/Down from current
Wallstreet Target Price - -
Analysts Target Price - -
ValueRay Target Price 140.8 1%